# FHIR Standards ## Profiles Used | Resource | Profile URL | | :--- | :--- | | **Patient** | `https://fhir.kemkes.go.id/r4/StructureDefinition/Patient` | | **Specimen** | `https://fhir.kemkes.go.id/r4/StructureDefinition/Specimen` | | **Organization** | `https://fhir.kemkes.go.id/r4/StructureDefinition/Organization` | | **Practitioner** | `https://fhir.kemkes.go.id/r4/StructureDefinition/Practitioner` | | **DiagnosticReport**| `http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomics-report` | | **Observation (Laboratory)**| `http://terminology.hl7.org/CodeSystem/observation-category` | | **Observation (Genetics)**| `http://terminology.hl7.org/CodeSystem/v2-0074` | | **Variant**| `http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant` | ## Standard Terminologies ### LOINC Codes (Sputum & Genomics) | Code | Display Name | Usage | | :--- | :--- | :--- | | **69548-6** | Genetic variant assessment | Observation (Variant) | | **89486-5** | Mycobacterial susceptibility panel | Observation (Panel) | | **81247-9** | Master HL7 genetic variant reporting panel | DiagnosticReport | | **81290-9** | Genomic DNA change (gHGVS) | Variant Component | | **48005-3** | Amino acid change (pHGVS) | Variant Component | | **48018-6** | Gene studied [ID] | Variant Component | | **48019-4** | DNA change type | Variant Component (SO terms) | | **53037-8** | Genetic variation clinical significance [Imp] | Variant Component (WHO Class) | | **81254-5** | Variant exact start-end | Variant Component | | **82121-5** | Allelic read depth | Variant Component | | **614-8** | Mycobacterial strain [Type] | Lineage Observation | ### LOINC Codes (Drug Susceptibility) Used within the Susceptibility Panel Observation. | Code | Display Name | | :--- | :--- | | **89489-9** | Rifampin [Susceptibility] by Genotype method | | **89488-1** | Isoniazid [Susceptibility] by Genotype method | | **92242-7** | Pyrazinamide [Susceptibility] by Genotype method | | **89491-5** | Ethambutol [Susceptibility] by Genotype method | | **96112-8** | Moxifloxacin [Susceptibility] by Genotype method | | **20629-2** | levoFLOXacin [Susceptibility] | | **96107-8** | Bedaquiline [Susceptibility] by Genotype method | | **96111-0** | Linezolid [Susceptibility] by Genotype method | | **96114-4** | Streptomycin [Susceptibility] by Genotype method | | **89484-0** | Amikacin [Susceptibility] by Genotype method | ### Sequence Ontology (SO) Used for **48019-4** (DNA change type). | Code | Display Name | | :--- | :--- | | **SO:0001583** | missense_variant | | **SO:0001819** | synonymous_variant | | **SO:0001587** | stop_gained | | **SO:0001578** | stop_lost | | **SO:0001589** | frameshift_variant | | **SO:0001821** | inframe_insertion | | **SO:0001822** | inframe_deletion | | **SO:0001629** | splice_site_variant | | **SO:0001631** | upstream_gene_variant | | **SO:0001632** | downstream_gene_variant | | **SO:0001628** | intergenic_variant | | **SO:0001627** | intron_variant | | **SO:0001623** | 5_prime_UTR_variant | | **SO:0001624** | 3_prime_UTR_variant | | **SO:0002012** | start_lost | | **SO:0001567** | stop_retained_variant | | **SO:0001818** | protein_altering_variant | | **SO:0001580** | coding_sequence_variant | | **SO:0001619** | non_coding_transcript_variant | | **SO:0001566** | regulatory_region_variant | **WHO Classification** | Code | Display Name | Usage | | :--- | :--- | :--- | | **LA26333-7** | http://loinc.org | Uncertain significance | | **SP000478** | http://terminology.kemkes.go.id/sp | Assoc w R | | **SP000479** | http://terminology.kemkes.go.id/sp | Assoc w R - Interim | | **SP000481** | http://terminology.kemkes.go.id/sp | Not assoc w R | | **SP000480** | http://terminology.kemkes.go.id/sp | Not assoc w R - Interim | ### Clinical Conclusion Codes Used in `DiagnosticReport.conclusionCode`. | Diagnosis | Code | System | | :--- | :--- | :--- | | **Sensitive** | **TB-SO** | `https://terminology.kemkes.go.id/CodeSystem/episodeofcare-type` | | **RR-TB** | **415345001** | `http://snomed.info/sct` | | **HR-TB** | **414546009** | `http://snomed.info/sct` | | **MDR-TB** | **423092005** | `http://snomed.info/sct` | | **Pre-XDR-TB** | **OV000435** | `http://terminology.kemkes.go.id/CodeSystem/clinical-term` | | **XDR-TB** | **710106005** | `http://snomed.info/sct` | | **Streptomycin mono-resistant** | **415622003** | `http://snomed.info/sct` | | **Ethionamide mono-resistant** | **414149006** | `http://snomed.info/sct` | | **Pyrazinamide mono-resistant** | **415222009** | `http://snomed.info/sct` | | **Ciprofloxacin mono-resistant** | **413852006** | `http://snomed.info/sct` | | **Ethambutol mono-resistant** | **414146004** | `http://snomed.info/sct` | | **Drug-resistant (Other)** | **413556004** | `http://snomed.info/sct` |